Reuters logo
BRIEF-Radius Health says FDA approves co's TYMLOS
April 28, 2017 / 3:56 PM / 8 months ago

BRIEF-Radius Health says FDA approves co's TYMLOS

April 28 (Reuters) - Radius Health Inc :

* FDA approves Radius Health’s TYMLOS™ (abaloparatide), a bone building agent for the treatment of postmenopausal women with osteoporosis at high risk for fracture

* US commercial launch in May for TYMLOS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below